Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Insulin resistance in PCOS.
Diamanti-Kandarakis E. Diamanti-Kandarakis E. Endocrine. 2006 Aug;30(1):13-7. doi: 10.1385/ENDO:30:1:13. Endocrine. 2006. PMID: 17185787 Review.
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.
Diamanti-Kandarakis E, Mitrakou A, Hennes MM, Platanissiotis D, Kaklas N, Spina J, Georgiadou E, Hoffmann RG, Kissebah AH, Raptis S. Diamanti-Kandarakis E, et al. Metabolism. 1995 Apr;44(4):525-31. doi: 10.1016/0026-0495(95)90062-4. Metabolism. 1995. PMID: 7723677 Clinical Trial.
The polycystic ovary syndrome. Pathogenesis, metabolic implications, and therapeutic approach.
Diamanti-Kandarakis E. Diamanti-Kandarakis E. Ann N Y Acad Sci. 1997 Jun 17;816:177-93. doi: 10.1111/j.1749-6632.1997.tb52142.x. Ann N Y Acad Sci. 1997. PMID: 9238268 Review. No abstract available.
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A. Diamanti-Kandarakis E, et al. Eur J Endocrinol. 1998 Mar;138(3):269-74. doi: 10.1530/eje.0.1380269. Eur J Endocrinol. 1998. PMID: 9539300 Clinical Trial.
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. Diamanti-Kandarakis E, et al. J Clin Endocrinol Metab. 1998 Aug;83(8):2699-705. doi: 10.1210/jcem.83.8.5041. J Clin Endocrinol Metab. 1998. PMID: 9709934
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Diamanti-Kandarakis E. Diamanti-Kandarakis E. J Endocrinol Invest. 1998 Oct;21(9):623-9. doi: 10.1007/BF03350788. J Endocrinol Invest. 1998. PMID: 9856417 Review. No abstract available.
Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome.
Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR. Diamanti-Kandarakis E, et al. Fertil Steril. 1999 Mar;71(3):431-5. doi: 10.1016/s0015-0282(98)00512-3. Fertil Steril. 1999. PMID: 10065777
Current aspects of antiandrogen therapy in women.
Diamanti-Kandarakis E. Diamanti-Kandarakis E. Curr Pharm Des. 1999 Sep;5(9):707-23. Curr Pharm Des. 1999. PMID: 10495361 Review.
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. Diamanti-Kandarakis E, et al. J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11. doi: 10.1210/jcem.84.11.6148. J Clin Endocrinol Metab. 1999. PMID: 10566641
Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.
Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, Tsianateli TC, Kouli CR. Diamanti-Kandarakis E, et al. Fertil Steril. 2000 Apr;73(4):735-41. doi: 10.1016/s0015-0282(99)00628-7. Fertil Steril. 2000. PMID: 10731534
197 results
Jump to page
Feedback